Zhou Li, Cheng Yan-ping
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Mar;36(3):322-6.
To explore the effect of electroacupuncture (EA) on the expression of Ghrelin and mRNA expression of its receptor in functional dyspepsia (FD) rats.
Totally 80 rats were divided into the normal group, the model group, the drug therapy group, and the EA group according to random digit table, 20 in each group. FD model was duplicated by clipping tail modeling. Drug containing cisapride [2 mL/100 g, 0.09 g/(kg x d)] was administered to rats in the drug therapy group from the 3rd day after successful modeling, once per day. EA at Zusanli (ST36) (0.3-0.5 cun) and Taichong (LR3) (0.1-0.2 cun) was performed in the EA group. The twirling of needle was performed to the subsidence of needle, and then the needle was connected to HANS-200A Acupoint Nerve Stimulating Device using disperse-dense wave at 2 Hz, 2 mA, 30 min each time, once per day. Six days consisted of one therapeutic course, two courses in total with an interval of one day. The intestinal propulsive rate of ink was observed. Ghrelin protein expression in gastric tissue was detected by Western blot. mRNA expression of growth hormone secretagogue receptor (GHS-R) in stomach, hypothalamus, and hippocampus was detected using Real-time PCR respectively.
Compared with the normal group, the intestinal propulsive rate of ink, Ghrelin protein expression in gastric tissue, mRNA expression of GHS-R in stomach, hypothalamus, and hippocampus decreased in the model group (P < 0.05, P < 0.01). Compared with the model group, the intestinal propulsive rate of ink, Ghrelin protein expression in gastric tissue, mRNA expression of GHS-R in stomach, hypothalamus, and hippocampus increased in the EA group (P < 0.01); mRNA expression of GHS-R in stomach, hypothalamus, and hippocampus increased in the drug therapy group (P < 0.01). Compared with the drug therapy group, Ghrelin protein expression in gastric tissue, mRNA expression of GHS-R in hypothalamus increased in the EA group (P < 0.05, P < 0.01).
EA could regulate Ghrelin content and GHS-R mRNA expression of FD rat hypothalamus, hippocampus, and gastric tissue, and promote the intestinal propulsive rate of ink.
探讨电针(EA)对功能性消化不良(FD)大鼠胃动素(Ghrelin)表达及其受体mRNA表达的影响。
将80只大鼠按随机数字表法分为正常组、模型组、药物治疗组和电针组,每组20只。采用夹尾造模法复制FD模型。药物治疗组在造模成功后第3天开始给予含西沙必利[2 mL/100 g,0.09 g/(kg·d)]的药物,每日1次。电针组取足三里(ST36)(0.3 - 0.5寸)和太冲(LR3)(0.1 - 0.2寸)进行电针治疗。行捻转补泻手法,使针下沉紧,然后将针连接到HANS - 200A穴位神经刺激仪,采用疏密波,频率2 Hz,电流2 mA,每次30 min,每日1次。6天为1个疗程,共2个疗程,疗程间隔1天。观察墨汁肠推进率。采用蛋白质免疫印迹法检测胃组织中Ghrelin蛋白表达。分别采用实时荧光定量聚合酶链反应(Real - time PCR)检测胃、下丘脑和海马组织中生长激素促分泌素受体(GHS - R)的mRNA表达。
与正常组比较,模型组墨汁肠推进率、胃组织中Ghrelin蛋白表达、胃、下丘脑和海马组织中GHS - R的mRNA表达均降低(P < 0.05,P < 0.01)。与模型组比较,电针组墨汁肠推进率、胃组织中Ghrelin蛋白表达、胃、下丘脑和海马组织中GHS - R的mRNA表达均升高(P < 0.01);药物治疗组胃、下丘脑和海马组织中GHS - R的mRNA表达升高(P < 0.01)。与药物治疗组比较,电针组胃组织中Ghrelin蛋白表达、下丘脑组织中GHS - R的mRNA表达升高(P < 0.05,P < 0.01)。
电针可调节FD大鼠下丘脑、海马及胃组织中Ghrelin含量及GHS - R mRNA表达,促进墨汁肠推进率。